(Q34110928)

31 July 2017

title

Comparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer (English)

1 reference

31 July 2017

1 reference

1 reference

Richard E J Forster

1

1 reference

31 July 2017

Sharon A Small

2

1 reference

31 July 2017

Yiqing Tang

3

1 reference

31 July 2017

Clare L Heaysman

4

1 reference

31 July 2017

Andrew W Lloyd

5

1 reference

31 July 2017

Wendy Macfarlane

6

1 reference

31 July 2017

Gary J Phillips

7

1 reference

31 July 2017

Milan D Antonijevic

8

1 reference

31 July 2017

Andrew L Lewis

9

1 reference

31 July 2017

publication date

19 June 2010

1 reference

Journal of Materials Science: Materials in Medicine

31 July 2017

published in

1 reference

31 July 2017

volume

21

1 reference

31 July 2017

issue

9

1 reference

31 July 2017

page(s)

2683-2690

1 reference

DC Bead: a major development in the toolbox for the interventional oncologist.

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

Doxorubicin and mitoxantrone drug eluting beads for the treatment of experimental peritoneal carcinomatosis in colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

Enhanced distribution of NK012, a polymeric micelle-encapsulated SN-38, and sustained release of SN-38 within tumors can beat a hypovascular tumor

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

Drug-loaded microspheres for the treatment of liver cancer: review of current results.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

The effect of quercetin on topotecan cytotoxicity in MCF-7 and MDA-MB 231 human breast cancer cells.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

Phase I study of topotecan in combination with concurrent radiotherapy in adults with glioblastoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

Camptothecins: from bench research to hospital wards.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

Doxorubicin and irinotecan drug-eluting beads for treatment of glioma: a pilot study in a rat model

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

Preservation of the active lactone form of irinotecan using drug eluting beads for the treatment of colorectal cancer metastases

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

Doxorubicin eluting beads-2: methods for evaluating drug elution and in-vitro:in-vivo correlation.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

Doxorubicin eluting beads - 1: effects of drug loading on bead characteristics and drug distribution.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer using irinotecan-eluting beads: preliminary results.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

Interaction of topotecan--a DNA topoisomerase inhibitor--with dual-stranded polydeoxyribonucleotides. I. Dimerization of topotecan in solution

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

Intratumoral infusion of topotecan prolongs survival in the nude rat intracranial U87 human glioma model

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2935541

A phase II trial of topotecan in patients with previously untreated pancreatic cancer

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20563626

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20563626

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitors

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20563626

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10856-010-4107-4

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference

31 July 2017

1 reference